Skip to main content

Advertisement

ADVERTISEMENT

Exclusives

News
06/12/2024
A 2,270-patient multicenter observational trial evaluating the short-term clinical impact of UrgoClean Ag on the wound healing process was published. The study demonstrates a reduction in wound size and exudate level across a range of wound...
A 2,270-patient multicenter observational trial evaluating the short-term clinical impact of UrgoClean Ag on the wound healing process was published. The study demonstrates a reduction in wound size and exudate level across a range of wound...
A 2,270-patient multicenter...
06/12/2024
Wound Care
News
06/12/2024
An 85-patient 2-part RCT will examine the efficacy of Dermacyte amniotic wound care matrix for the treatment of DFUs vs SoC with primary outcome of wound closure at 12 weeks. Not yet recruiting; the estimated study completion is May 2025....
An 85-patient 2-part RCT will examine the efficacy of Dermacyte amniotic wound care matrix for the treatment of DFUs vs SoC with primary outcome of wound closure at 12 weeks. Not yet recruiting; the estimated study completion is May 2025....
An 85-patient 2-part RCT will...
06/12/2024
Wound Care
News
06/12/2024
Avita achieves a milestone with the first US burn center to treat a patient using its RECELL GO System. The product is a next-generation autologous cell harvesting device that uses a patient’s own skin to treat thermal burn wounds and...
Avita achieves a milestone with the first US burn center to treat a patient using its RECELL GO System. The product is a next-generation autologous cell harvesting device that uses a patient’s own skin to treat thermal burn wounds and...
Avita achieves a milestone with...
06/12/2024
Wound Care
News
06/12/2024
Mölnlycke is partnering with Yuncture, an entrepreneurial incubator, to identify and collaborate with start-ups through the “Yuncture incubator program.” The partnership will run from Sept 2024 to Jan 2025.
Mölnlycke is partnering with Yuncture, an entrepreneurial incubator, to identify and collaborate with start-ups through the “Yuncture incubator program.” The partnership will run from Sept 2024 to Jan 2025.
Mölnlycke is partnering with...
06/12/2024
Wound Care
News
06/12/2024
Case series with OptiView Transparent Gel Dressing reported a 74.9% average reduction in deep-tissue pressure injury wound area. The average time to wound closure that completely healed after dressing application was 18.3 days. SAWC Spring...
Case series with OptiView Transparent Gel Dressing reported a 74.9% average reduction in deep-tissue pressure injury wound area. The average time to wound closure that completely healed after dressing application was 18.3 days. SAWC Spring...
Case series with OptiView...
06/12/2024
Wound Care
News
06/12/2024
A 60-patient RCT found that Altrazeal transforming powder dressing (TPD) was associated with higher healing rates, shorter duration of healing, less pain, and decreased dressing changes compared to current SOC in the treatnebt of CVUs. SAWC...
A 60-patient RCT found that Altrazeal transforming powder dressing (TPD) was associated with higher healing rates, shorter duration of healing, less pain, and decreased dressing changes compared to current SOC in the treatnebt of CVUs. SAWC...
A 60-patient RCT found that...
06/12/2024
Wound Care
SAWC Spring 2024: Highlighting the Hot Topic of Skin Substitute Reimbursement
Blog
06/12/2024
This blog was originally posted on SmartTrak's website on June 19, 2024: https://blog.smarttrak.com/sawc-spring-2024-highlighting-the-hot-topic-of-skin-substitute-reimbursement. Reposted with permission. The proposed MAC LCDs for...
This blog was originally posted on SmartTrak's website on June 19, 2024: https://blog.smarttrak.com/sawc-spring-2024-highlighting-the-hot-topic-of-skin-substitute-reimbursement. Reposted with permission. The proposed MAC LCDs for...
This blog was originally...
06/12/2024
Wound Care
News
06/05/2024
CMS released 4 new A codes at the First CMS Biannual 2024 HCPCS Public Meeting including xenoPatch (manufactured by DSM) for Extremity Care, MatriDerm (manufactured by MedSkin) for Access Medical, MicroMatrix Flex for Integra, and MiroTract...
CMS released 4 new A codes at the First CMS Biannual 2024 HCPCS Public Meeting including xenoPatch (manufactured by DSM) for Extremity Care, MatriDerm (manufactured by MedSkin) for Access Medical, MicroMatrix Flex for Integra, and MiroTract...
CMS released 4 new A codes at...
06/05/2024
Wound Care
News
06/05/2024
A retrospective 134-patient study compared the use of polyhexamethylene biguanide and betaine (PHMB-B) vs saline when used as the install solution in NPWT for diabetic foot infections (DFIs) and found no difference in length of stay, cost of...
A retrospective 134-patient study compared the use of polyhexamethylene biguanide and betaine (PHMB-B) vs saline when used as the install solution in NPWT for diabetic foot infections (DFIs) and found no difference in length of stay, cost of...
A retrospective 134-patient...
06/05/2024
Wound Care
News
06/05/2024
In May 2024, BioMonde was awarded a share of ~$1.1MM (£900k) of funding support from the Welsh government-backed SMART FIS program. The funding will be used to develop products from larval secretions.
In May 2024, BioMonde was awarded a share of ~$1.1MM (£900k) of funding support from the Welsh government-backed SMART FIS program. The funding will be used to develop products from larval secretions.
In May 2024, BioMonde was...
06/05/2024
Wound Care

Advertisement

Advertisement

Advertisement